Document is current
Any future updates will be listed below
-
Authors
Martin, Isaac https://orcid.org/0000-0002-4828-0369
Silverberg, Mary https://orcid.org/0000-0002-0857-2420
Abdelgawad, Ahmed https://orcid.org/0000-0003-4723-5686
Tanaka, Kosuke https://orcid.org/0000-0001-5436-6399
Halloran, Brian A. https://orcid.org/0000-0003-4259-4524
Nicola, Teodora https://orcid.org/0000-0002-0815-6785
Myers, Erin D. https://orcid.org/0000-0003-3939-8995
Desai, Jay P. https://orcid.org/0000-0002-7072-2899
White, Catrina T. https://orcid.org/0000-0002-7154-8634
Karabayir, Ibrahim https://orcid.org/0000-0002-7928-176X
Akbilgic, Oguz https://orcid.org/0000-0003-0313-9254
Tipton, Laura https://orcid.org/0000-0002-5118-2671
Gentle, Samuel J. https://orcid.org/0000-0003-0238-6472
Ambalavanan, Namasivayam https://orcid.org/0000-0003-0731-9092
Peters, Brian M. https://orcid.org/0000-0002-0445-2077
Vu, Luan D. https://orcid.org/0000-0001-8493-1811
Jain, Viral G. https://orcid.org/0000-0002-1897-6461
Lal, Charitharth V. https://orcid.org/0000-0001-9071-4047
Cormier, Stephania A. https://orcid.org/0000-0002-6050-6172
Pierre, Joseph F. https://orcid.org/0000-0002-4248-1290
Jilling, Tamás https://orcid.org/0000-0002-6200-3851
Talati, Ajay J. https://orcid.org/0000-0002-7980-3679
Willis, Kent A. https://orcid.org/0000-0001-7338-0399
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21 HD100917)
National Heart, Lung, and Blood Institute (R01 HL156275, KL2 TR3097, K08 HL141652, K08 HL151907)
National Institute of Allergy and Infectious Diseases (R01 AI134796, R21 AI163503)
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 7 January 2025
First Online: 27 January 2025
Declarations
:
: The human study protocol was approved by the Institutional Review Board of The University of Tennessee under protocol 17–05311-XP and conducted in accordance with the Declaration of Helsinki. The human cohort for FMT samples was approved under protocol IRB-300003994 by the IRB at the University of Alabama at Birmingham (UAB, Birmingham, AL, USA). Mouse experiments were performed at UAB under IACUC protocol 22042.
: Assent for publication was obtained from the mother during study enrollment.
: CL is the founder of ResBiotic Nutrition, Inc. and Alveolus Bio, Inc., from which he reports salary and stock options, and TN is now an employee, thereof. KW and NA are scientific advisors to these companies and report consulting fees and stock options from the same. The remaining authors report no disclosures.
